Platform
Workflows
Antibody Discovery
Viral Neutralization
Cell Line Development
Cell Therapy Development
Synthetic Biology
Advanced Automation
The Beacon
®
Optofluidic System
The Lightning™ Optofluidic System
The Culture Station™ System
Technology
Company
News
Press Releases
Customer Spotlights
Blog
Newsletter
Events
Investors
Careers
Resources
Support
Get In Touch
Latest
News
News
04.12.21
Military programs aiming to end pandemics forever
News
03.05.21
From Discovery To Delivery: Addressing Challenges in Cell Therapy
News
03.04.21
Biotech’s Brave New World: Bay Area startups band together to ramp up coronavirus research and testing
News
01.13.21
JP Morgan Healthcare Conference 2021, Day Two:Qiagen, Invitae, Agilent, Sema4, More
News
11.05.20
Finding the Best Cell for the Job
News
11.01.20
Pinpointing Bioprocess Development Success
News
10.21.20
Big Tech Is Under Pressure. Here’s Where to Find Growth
News
10.05.20
Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells
News
10.01.20
Soaring Biomedical IPOs Raise Questions About Money Left on the Table
News
09.22.20
Berkeley Lights Will Receive IPO of the Year Award at SynBioBeta 2020
News
09.14.20
Optofluidics Technology Accelerates Discovery of COVID-19 Treatments
News
09.13.20
Q&A: Distributed Biological Processing Can Prevent Pandemics
News
09.11.20
Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9 Billion
News
08.12.20
Health Care CEO Does 180 Zoom Calls In Three Days to Help Take Company Public
News
08.11.20
A Singular View of COVID-19
News
08.04.20
Samsung Biologics Launches S-CHOice Cell Line Expression Technology
News
07.22.20
Light-Based Chips Speed up Cell-Line Development for GSK
News
07.20.20
Berkeley Lights flies high with $178M IPO
1
2
3